\-\ Texto\\:\\ \ \(0\)\
\-\ \\.\\ \\ activity\\ within\\ the\\ kidneys\\ and\\ bladders\\ and\\ soft\\ tissues\\ are\ \(0\)\
\-\ unremarkable\\.2\\.\\ \\ there\\ is\\ increased\\ radiotracer\\ uptake\\ within\\ the\\ vertebral\\ body\\ and\\ left\ \(0\)\
\-\ posterior\\ rib\\ at\\ t5\\.\\ \\ there\\ is\\ also\\ increased\\ uptake\\ in\\ the\\ l4\\ vertebral\\ body\ \(0\)\
\-\ and\\ including\\ the\\ pedicles\\ at\\ this\\ level\\.\\ \\ there\\ is\\ increased\\ uptake\\ with\ \(0\)\
\-\ mild\\ expansion\\ of\\ the\\ sacrum\\.\\ \\ there\\ is\\ increased\\ uptake\\ and\\ expansion\\ of\\ the\ \(0\)\
\-\ left\\ iliac\\ crest\\ and\\ into\\ the\\ pubic\\ symphysis\\.\\ \\ the\\ remainder\\ of\\ the\\ skeleton\ \(0\)\
\-\ is\\ unremarkable\\.\ \(29\)\
\-\ paget\\ disease\\ of\\ bone\ \(0\)\
\-\ paget\\â\\€\\™s\\ disease\ \(0\)\
\-\ primary\\ bone\\ tumor\ \(12\)\
\-\ bony\\ metastasis\ \(0\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ 74\\ year\\ old\\ female\\ with\\ paget\\â\\€\\™s\\ disease\\.\ \(0\)\
\-\ paget\\â\\€\\™s\\ disease\\,\\ also\\ known\\ as\\ osteitis\\ deformans\\,\\ is\\ thought\\ to\\ be\\ caused\\ by\\ a\\ virus\\ and\\ may\\ affect\\ up\\ to\\ 3\\%\\ of\\ the\\ population\\ over\\ four\\ years\\ of\\ age\\.\\ \\ it\\ will\\ demonstrate\\ increased\\ bone\\ resorption\\ and\\ bone\\ formation\\.\\ \\ however\\,\\ the\\ newly\\ formed\\ bone\\ will\\ be\\ abnormally\\ soft\\.\\ \\ during\\ bone\\ formation\\,\\ the\\ patient\\ may\\ have\\ an\\ increase\\ in\\ their\\ alkaline\\ phosphatase\\.\\ \\ however\\,\\ their\\ calcium\\ and\\ phosphorus\\ levels\\ should\\ remain\\ normal\\.\\ \\ during\\ bone\\ resorption\\,\\ they\\ may\\ have\\ an\\ increased\\ hydroxyproline\\ level\\.\\ \\ paget\\â\\€\\™s\\ disease\\ typically\\ involves\\ the\\ spine\\,\\ pelvis\\,\\ and\\ proximal\\ long\\ bones\\.\\ \\ it\\ is\\ divided\\ into\\ three\\ phases\\:\\ osteolytic\\ phase\\,\\ osteoblastic\\ and\\ mixed\\ phases\\.\\ \\ the\\ initial\\ osteolytic\\ or\\ the\\ active\\ phase\\ is\\ characterized\\ by\\ aggressive\\ bone\\ resorption\\ and\\ lytic\\ lesions\\.\\ \\ the\\ osteoblastic\\ phase\\ or\\ inactive\\ phase\\ is\\ distinguished\\ by\\ abnormal\\ bone\\ production\\ such\\ as\\ cortical\\ thickening\\ and\\ bone\\ widening\\.\\ \\ overall\\ bone\\ density\\ is\\ also\\ increased\\ at\\ this\\ phase\\.\\ the\\ mixed\\ phase\\ demonstrates\\ bone\\ resorption\\ and\\ formation\\ and\\ bowing\\ of\\ bones\\ is\\ prominent\\ at\\ this\\ time\\.\\ bone\\ scans\\ are\\ performed\\ with\\ tc99m\\ hdp\\ which\\ will\\ show\\ striking\\ uptake\\ during\\ the\\ osteoblastic\\ phase\\ and\\ will\\ typically\\ show\\ enlargement\\ of\\ the\\ bone\\ along\\ with\\ characteristic\\ paget\\â\\€\\™s\\ disease\\ bone\\ deformities\\ and\\ expansion\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bone\\:\\ 0\\.4116442931611703\ \(0\)\
\-\ phase\\:\\ 0\\.3012648478793218\ \(0\)\
\-\ paget\\:\\ 0\\.2992576606051892\ \(0\)\
\-\ resorption\\:\\ 0\\.22622738848445337\ \(0\)\
\-\ uptake\\:\\ 0\\.1933725770301561\ \(0\)\
\-\ the\\:\\ 0\\.19068083409649803\ \(0\)\
\-\ increased\\:\\ 0\\.19038301688405232\ \(0\)\
\-\ and\\:\\ 0\\.17668117137133188\ \(0\)\
\-\ osteoblastic\\:\\ 0\\.16880321055152836\ \(0\)\
\-\ is\\:\\ 0\\.15151229415308892\ \(0\)\
\-\ expansion\\:\\ 0\\.1375607936530335\ \(0\)\
\-\ will\\:\\ 0\\.12948687479348034\ \(0\)\
\-\ disease\\:\\ 0\\.12667432553628757\ \(0\)\
\-\ formation\\:\\ 0\\.11962199143718599\ \(0\)\
\-\ osteolytic\\:\\ 0\\.11779914280717108\ \(0\)\
\-\ phases\\:\\ 0\\.11563715549128185\ \(0\)\
\-\ during\\:\\ 0\\.09557173051093672\ \(0\)\
\-\ their\\:\\ 0\\.08348467805380906\ \(0\)\
\-\ mixed\\:\\ 0\\.08326696977556163\ \(0\)\
\-\ bones\\:\\ 0\\.08093932462744674\ \(0\)\
\-\ bladders\\:\\ 0\\.08043392418481266\ \(0\)\
\-\ there\\:\\ 0\\.08005016151618917\ \(0\)\
\-\ of\\:\\ 0\\.0787413142775338\ \(0\)\
\-\ vertebral\\:\\ 0\\.07681577624478857\ \(0\)\
\-\ at\\:\\ 0\\.07598943263149202\ \(0\)\
\-\ may\\:\\ 0\\.0759312885592352\ \(0\)\
\-\ hydroxyproline\\:\\ 0\\.07432239470135642\ \(0\)\
\-\ deformans\\:\\ 0\\.07235492165789942\ \(0\)\
\-\ also\\:\\ 0\\.07097310029975988\ \(0\)\
\-\ typically\\:\\ 0\\.07061639540847041\ \(0\)\
\-\ unremarkable\\:\\ 0\\.06743654342741014\ \(0\)\
\-\ inactive\\:\\ 0\\.06717236356160917\ \(0\)\
\-\ body\\:\\ 0\\.06620228768492954\ \(0\)\
\-\ pedicles\\:\\ 0\\.06540303533496634\ \(0\)\
\-\ phosphorus\\:\\ 0\\.06463584964802657\ \(0\)\
\-\ by\\:\\ 0\\.06407553359396635\ \(0\)\
\-\ show\\:\\ 0\\.0638578548421624\ \(0\)\
\-\ osteitis\\:\\ 0\\.06327669180813165\ \(0\)\
\-\ crest\\:\\ 0\\.06209933573444398\ \(0\)\
\-\ hdp\\:\\ 0\\.06209933573444398\ \(0\)\
\-\ symphysis\\:\\ 0\\.061060834078152944\ \(0\)\
\-\ level\\:\\ 0\\.06076313985776713\ \(0\)\
\-\ t5\\:\\ 0\\.06013186269098698\ \(0\)\
\-\ striking\\:\\ 0\\.05970167623825803\ \(0\)\
\-\ however\\:\\ 0\\.05953845916675238\ \(0\)\
\-\ distinguished\\:\\ 0\\.05929150585151013\ \(0\)\
\-\ newly\\:\\ 0\\.058164389647529964\ \(0\)\
\-\ virus\\:\\ 0\\.05781857774564093\ \(0\)\
\-\ phosphatase\\:\\ 0\\.05781857774564093\ \(0\)\
\-\ pubic\\:\\ 0\\.05685575958647671\ \(0\)\
\-\ bowing\\:\\ 0\\.05685575958647671\ \(0\)\
\-\ alkaline\\:\\ 0\\.05655684712111334\ \(0\)\
\-\ divided\\:\\ 0\\.05598780625098776\ \(0\)\
\-\ sacrum\\:\\ 0\\.05571649028163649\ \(0\)\
\-\ tc99m\\:\\ 0\\.05545327451797946\ \(0\)\
\-\ skeleton\\:\\ 0\\.054707725831537296\ \(0\)\
\-\ formed\\:\\ 0\\.054707725831537296\ \(0\)\
\-\ production\\:\\ 0\\.054020333207530746\ \(0\)\
\-\ soft\\:\\ 0\\.053552820978764945\ \(0\)\
\-\ into\\:\\ 0\\.05347275661168623\ \(0\)\
\-\ affect\\:\\ 0\\.05205286016407374\ \(0\)\
\-\ this\\:\\ 0\\.051847621812767676\ \(0\)\
\-\ it\\:\\ 0\\.05149142804037869\ \(0\)\
\-\ deformities\\:\\ 0\\.05105363284121921\ \(0\)\
\-\ remain\\:\\ 0\\.05089757437294367\ \(0\)\
\-\ have\\:\\ 0\\.05025101590806401\ \(0\)\
\-\ 74\\:\\ 0\\.050015131184928174\ \(0\)\
\-\ abnormally\\:\\ 0\\.050015131184928174\ \(0\)\
\-\ l4\\:\\ 0\\.04801971176854078\ \(0\)\
\-\ population\\:\\ 0\\.04758421222539615\ \(0\)\
\-\ widening\\:\\ 0\\.04639358741590406\ \(0\)\
\-\ within\\:\\ 0\\.04632938363571679\ \(0\)\
\-\ iliac\\:\\ 0\\.04630126119765791\ \(0\)\
\-\ characterized\\:\\ 0\\.04620989174500088\ \(0\)\
\-\ overall\\:\\ 0\\.04620989174500088\ \(0\)\
\-\ rib\\:\\ 0\\.045941330680617516\ \(0\)\
\-\ calcium\\:\\ 0\\.04542756944785768\ \(0\)\
\-\ remainder\\:\\ 0\\.04426061700166382\ \(0\)\
\-\ radiotracer\\:\\ 0\\.04390360170147196\ \(0\)\
\-\ involves\\:\\ 0\\.04376474728407531\ \(0\)\
\-\ scans\\:\\ 0\\.04376474728407531\ \(0\)\
\-\ aggressive\\:\\ 0\\.043493431314724045\ \(0\)\
\-\ thought\\:\\ 0\\.043426887049592515\ \(0\)\
\-\ kidneys\\:\\ 0\\.04329528649790986\ \(0\)\
\-\ lytic\\:\\ 0\\.04236631511074389\ \(0\)\
\-\ be\\:\\ 0\\.0408059858962472\ \(0\)\
\-\ four\\:\\ 0\\.040758772584327266\ \(0\)\
\-\ characteristic\\:\\ 0\\.04066134536895993\ \(0\)\
\-\ as\\:\\ 0\\.0404112110098743\ \(0\)\
\-\ increase\\:\\ 0\\.0403753611658513\ \(0\)\
\-\ caused\\:\\ 0\\.04032858613159832\ \(0\)\
\-\ levels\\:\\ 0\\.03987399714572867\ \(0\)\
\-\ tissues\\:\\ 0\\.03965519998119338\ \(0\)\
\-\ prominent\\:\\ 0\\.03961208462252601\ \(0\)\
\-\ with\\:\\ 0\\.039394181097025804\ \(0\)\
\-\ fibrous\\:\\ 0\\.03906996613447221\ \(0\)\
\-\ bony\\:\\ 0\\.038752199373564354\ \(0\)\
\-\ enlargement\\:\\ 0\\.03855925790495549\ \(0\)\
\-\ dysplasia\\:\\ 0\\.03852117113610805\ \(0\)\
\-\ an\\:\\ 0\\.03846588566509754\ \(0\)\
\-\ are\\:\\ 0\\.03816993284018438\ \(0\)\
\-\ active\\:\\ 0\\.03734856692094445\ \(0\)\
\-\ activity\\:\\ 0\\.03692630592787546\ \(0\)\
\-\ metastasis\\:\\ 0\\.03686310083084975\ \(0\)\
\-\ cortical\\:\\ 0\\.036109045560749176\ \(0\)\
\-\ including\\:\\ 0\\.0359941635019132\ \(0\)\
\-\ they\\:\\ 0\\.035937278960873204\ \(0\)\
\-\ pelvis\\:\\ 0\\.035177183803690726\ \(0\)\
\-\ or\\:\\ 0\\.03499402235944195\ \(0\)\
\-\ left\\:\\ 0\\.03431398463481537\ \(0\)\
\-\ thickening\\:\\ 0\\.0342170566481421\ \(0\)\
\-\ three\\:\\ 0\\.03376246766227244\ \(0\)\
\-\ initial\\:\\ 0\\.03374034199626267\ \(0\)\
\-\ along\\:\\ 0\\.033696256538027665\ \(0\)\
\-\ long\\:\\ 0\\.03335129035800183\ \(0\)\
\-\ density\\:\\ 0\\.03335129035800183\ \(0\)\
\-\ spine\\:\\ 0\\.03322533002610404\ \(0\)\
\-\ should\\:\\ 0\\.0328180024809987\ \(0\)\
\-\ known\\:\\ 0\\.03256298592257499\ \(0\)\
\-\ such\\:\\ 0\\.03235281821250873\ \(0\)\
\-\ age\\:\\ 0\\.03157619745428015\ \(0\)\
\-\ proximal\\:\\ 0\\.03142195900320129\ \(0\)\
\-\ primary\\:\\ 0\\.030926487464458925\ \(0\)\
\-\ years\\:\\ 0\\.030830648767837986\ \(0\)\
\-\ abnormal\\:\\ 0\\.030217039614385228\ \(0\)\
\-\ time\\:\\ 0\\.029811585501233608\ \(0\)\
\-\ performed\\:\\ 0\\.029755156039641135\ \(0\)\
\-\ lesions\\:\\ 0\\.028885445089618694\ \(0\)\
\-\ mild\\:\\ 0\\.028511255700821938\ \(0\)\
\-\ over\\:\\ 0\\.027966672747289235\ \(0\)\
\-\ tumor\\:\\ 0\\.02630761844858335\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02614738929762026\ \(0\)\
\-\ posterior\\:\\ 0\\.026008388942056426\ \(0\)\
\-\ demonstrates\\:\\ 0\\.025268060032744333\ \(0\)\
\-\ to\\:\\ 0\\.0251476994555825\ \(0\)\
\-\ in\\:\\ 0\\.0250239225309448\ \(0\)\
\-\ up\\:\\ 0\\.024879434124102755\ \(0\)\
\-\ female\\:\\ 0\\.02427004044542734\ \(0\)\
\-\ which\\:\\ 0\\.022869997994805706\ \(0\)\
\-\ normal\\:\\ 0\\.020535435482046557\ \(0\)\
\-\ patient\\:\\ 0\\.016358696913237946\ \(0\)\
\-\ year\\:\\ 0\\.015500173500631102\ \(0\)\
\-\ old\\:\\ 0\\.014885532078816889\ \(0\)\
